Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Acid production inhibitors

Fig. 3. Schematic process flow diagram for an imitation cheese product having the following formulation dry ingredients, calcium caseinate (or rennet casein), 24.5 wt % tapioca flour, 3.0 wt % salt, 2.16 wt % adipic acid, 0.6 wt % vitamins and minerals, 0.1 wt % sorbic acid (mold inhibitor), 0.5 wt % fat—color blend, soybean oil hydrogenated to a Wiley melting point of 36°C, 21.3 wt % lactylated monoglycerides, 0.05 wt % red-orange coloring, 0.01 wt... Fig. 3. Schematic process flow diagram for an imitation cheese product having the following formulation dry ingredients, calcium caseinate (or rennet casein), 24.5 wt % tapioca flour, 3.0 wt % salt, 2.16 wt % adipic acid, 0.6 wt % vitamins and minerals, 0.1 wt % sorbic acid (mold inhibitor), 0.5 wt % fat—color blend, soybean oil hydrogenated to a Wiley melting point of 36°C, 21.3 wt % lactylated monoglycerides, 0.05 wt % red-orange coloring, 0.01 wt...
Chemical Reactivity - Reactivity with Water No reaction Reactivity with Common Materials No reactions Stability During Transport Stable Neutralizing Agents for Acids and Caustics Not pertinent Polymerization Polymerization can occur when this product is exposed to high temperatures or is contaminated with alkalies, aqueous acids, amines, and acidic alcohols Inhibitor of Polymerization Not pertinent. [Pg.333]

Compounds 111 having structural features of the dual cyclooxygenase (COX)/5-lipooxygenase (5-LO) inhibitor tepoxalin and the 5-LO inhibitor ABT-761 were prepared. Many of these hybrid compounds are potent COX and 5-LO inhibitors two compounds (111, r =McO, R = R" = R = H, R = NH2, R = Me and r = MeO, R = R = Me, R" = R = H, R = Cl) inhibited eicosanoid biosynthesis in an ex vivo assay, but neither improved on the main deficiency of tepoxalin, duration of 5-LO inhibitory activity (99BMCL979). Compounds 111 inhibit the production of arachidonic acid products associated with 5-lipoxygenase and cyclooxygenase and are useful in the treatment of inflammatory disorders (99USP5925769). [Pg.85]

Another major cause of wear is the chemical action associated with the inevitable acidic products of fuel combustion. This chemical wear of cylinder bores can be prevented by having an oil film which is strongly adherent to the metal surfaces involved, and which will rapidly heal when a tiny mpture occurs. This is achieved by the use of a chemical additive known as a corrosion inhibitor. [Pg.848]

Schering Plough has reported the discovery of the first non-hydroxamic acid containing natural product inhibitors of PDF. Sch 382582 (41) and Sch 382583 (42) were isolated from a fermentation broth of Streptomyces sp., and the proposed structures of these compoimds were derived from a combination of two-dimensional NMR studies (NOESY, HMBC and HMQC-TOCSY) and X-ray crystallography studies [116]. The proposed structure... [Pg.133]

A large number of in vitro inhibitors of PAL are known, however, few of these effectively inhibit PAL activity in vivo without also causing phytotoxic effects unrelated to their effects on PAL. PAL inhibitors fall into four categories 1) PAL product-inhibitors such as t-cinnamic acid and p-coumaric acid (e.g. 35) ... [Pg.119]

Several observations regarding this aspect have been published, and are briefly mentioned here. 5,6-Dideoxy-6-C-phosphono-D-arabino-hexofuranose (135), an isosteric phosphonate analog of D-arabinose 5-phosphate, is apparently converted, in the presence of enolpyruvate phosphate, into 3,8,9-trideoxy-9-C-phosphono-D-mcmno-2-nonulosonic acid (136) under catalysis by KDO 8-phosphate synthetase from Escherichia coli K 235. Compound 136, an isosteric phosphonate analog of KDO 8-phosphate, is a product inhibitor of the synthetase, and, by the nature of the phosphonate group, is not subject to dephosphorylation as catalyzed by KDO 8-phosphate phosphatase156 (see Scheme 40). Compound 119 (see Scheme 33) is a weak inhibitor of KDO 8-phosphate synthetase.81 KDO inhibits KDO 8-phosphate phosphatase,139 and D-ribose 5-phosphate has an inhibitory... [Pg.387]

HDAC inhibitors have received tremendous attention with the recent FDA approval of Vorinostat (Zolinza) or suberoylanilide hydroxamic acid (SAHA) for the treatment of cutaneous T-cell lymphoma (CTCL). Multiple compounds have thus entered into clinical trials for a wide variety of diseases. Many of these compounds were inspired in some part from HDAC natural product inhibitors. In addition, one natural product Romidepsin has also gained FDA approval for treating cutaneous T-cell lymphoma. [Pg.275]

Omeprazole is an antiulcer drug. It is a proton pump inhibitor. This substituted benzimidazole inhibits gastric acid secretion to help acid/peptic disorders and duodenal ulcers. It interferes with the proton pump in the mucous lining of the stomach, the last stage of acid production. It can turn off stomach acid in as little as one hour. Lansoprazole (no. 12) has a similar structure. [Pg.425]

H2-receptor antagonists are drugs used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia however, their use has waned since the advent of the more effective proton pump inhibitors. [Pg.221]

Treatment with allopurinol, an inhibitor of xanthine oxidase, leads to decreased uric acid production. [Pg.146]

Mechanism of Action A xanthine oxidase inhibitor that decreases uric acid production by inhibiting xanthine oxidase, an enzyme. Therapeutic Effect Reduces uric acid concentrations in both serum and urine. [Pg.32]

Mechanism of Action Aproton pump inhibitor that is converted to active metabolites that irreversibly bind to and inhibit hydrogen-potassium adenosine triphosphates, an enzyme on the surface of gastricparietal cells. Inhibits hydrogen ion transport into gastric lumen. Therapeutic Effect Increases gastricpH, reducing gastric acid production. [Pg.457]

Caustic-resistant corrosion inhibitors have been developed to help overcome this neutralization concern. However, these products must often be used at higher concentrations than carboxylic acid based inhibitors. Also, some caustic-resistant inhibitors tend to emulsify with water later in the fuel distribution channel. [Pg.210]

This problem is not common and is not expected. However, in a situation of gross overtreatment with an amine-based processing aid, interaction with a carboxylic acid based corrosion inhibitor is possible. In dilute solution within the fuel, it is unlikely that these compounds will react since only low levels, <5 ppm, of filmer or neutralizer will typically carry over into finished fuel. If the two do react, the product formed will provide corrosion protection, but not as effectively as the unreacted carboxylic acid based inhibitor. [Pg.211]

Reactivity with Common Materials Slow hydrolysis to acidic products Stability During Transport Stable Neutralizing Agents for Acids and Caustics Not pertinent Polymerization Not pertinent Inhibitor of Polymerization Not pertinent. [Pg.361]


See other pages where Acid production inhibitors is mentioned: [Pg.522]    [Pg.488]    [Pg.522]    [Pg.488]    [Pg.186]    [Pg.282]    [Pg.476]    [Pg.174]    [Pg.251]    [Pg.283]    [Pg.294]    [Pg.175]    [Pg.163]    [Pg.190]    [Pg.786]    [Pg.403]    [Pg.261]    [Pg.1386]    [Pg.10]    [Pg.66]    [Pg.604]    [Pg.1073]    [Pg.268]    [Pg.515]    [Pg.117]    [Pg.241]    [Pg.435]    [Pg.251]    [Pg.787]    [Pg.21]    [Pg.22]    [Pg.717]    [Pg.66]    [Pg.657]   
See also in sourсe #XX -- [ Pg.170 ]




SEARCH



Acid inhibitors

Product inhibitors

Proton pump inhibitors gastric acid production

© 2024 chempedia.info